Trial record 1 of 1 for:    rtog 1306
Previous Study | Return to List | Next Study

Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01822496
Recruitment Status : Active, not recruiting
First Posted : April 2, 2013
Last Update Posted : April 13, 2018
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : December 31, 2021
  Study Completion Date : No date given